Anthony J. Burke

Coimbra, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Moving forward with molecular skeleton editing (MSE) for new drug discovery: where to next?

Moving forward with molecular skeleton editing (MSE) for new drug discovery: where to next?

Journal: Expert opinion on drug discovery

Published: June 08, 2026

Stereochemical Terminology in Chiral Drugs: Still Between Confusion and Misinterpretation.

Stereochemical Terminology in Chiral Drugs: Still Between Confusion and Misinterpretation.

Journal: ACS medicinal chemistry letters

Published: April 08, 2026

Novel Bioinspired Quercetin-Based Polymers for the Sustained Release of Donepezil in Alzheimer's Disease Therapy.

Novel Bioinspired Quercetin-Based Polymers for the Sustained Release of Donepezil in Alzheimer's Disease Therapy.

Journal: Polymers

Published: November 13, 2025

Exploring the potential of new acetylated unsaturated Oxindole derivatives as multi-target inhibitors for BACE1 and BuChE.

Exploring the potential of new acetylated unsaturated Oxindole derivatives as multi-target inhibitors for BACE1 and BuChE.

Journal: Bioorganic & medicinal chemistry

Published: March 29, 2025

5th International Symposium on Synthesis and Catalysis (ISySyCat2023).

5th International Symposium on Synthesis and Catalysis (ISySyCat2023).

Journal: Beilstein journal of organic chemistry

Published: October 06, 2024

Targeting Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2): Latest Insights on Synthetic Strategies.

Targeting Vascular Endothelial Growth Factor Receptor 2 (VEGFR-2): Latest Insights on Synthetic Strategies.

Journal: Molecules (Basel, Switzerland)

Published: September 30, 2024

Assessing the Potential of 1,2,3-Triazole-Dihydropyrimidinone Hybrids Against Cholinesterases: In Silico, In Vitro, and In Vivo Studies.

Assessing the Potential of 1,2,3-Triazole-Dihydropyrimidinone Hybrids Against Cholinesterases: In Silico, In Vitro, and In Vivo Studies.

Journal: International journal of molecular sciences

Published: September 19, 2024

What is the future of click chemistry in drug discovery and development?

What is the future of click chemistry in drug discovery and development?

Journal: Expert opinion on drug discovery

Published: January 12, 2024

Metal-catalyzed coupling/carbonylative cyclizations for accessing dibenzodiazepinones: an expedient route to clozapine and other drugs.

Metal-catalyzed coupling/carbonylative cyclizations for accessing dibenzodiazepinones: an expedient route to clozapine and other drugs.

Journal: Beilstein journal of organic chemistry

Published: November 18, 2023

Early pharmacological profiling of isatin derivatives as potent and selective cytotoxic agents.

Early pharmacological profiling of isatin derivatives as potent and selective cytotoxic agents.

Journal: Biochemical pharmacology

Published: November 03, 2023

Quercetin-1,2,3-Triazole Hybrids as Multifunctional Anti-Alzheimer's Agents.

Quercetin-1,2,3-Triazole Hybrids as Multifunctional Anti-Alzheimer's Agents.

Journal: Molecules (Basel, Switzerland)

Published: October 09, 2023

Asymmetric organocatalysis in drug discovery and development for active pharmaceutical ingredients.

Asymmetric organocatalysis in drug discovery and development for active pharmaceutical ingredients.

Journal: Expert opinion on drug discovery

Published: December 17, 2022

Showing 1-12 of 33

Last Updated: 09/26/2026